MDLN
MDLN
US58507V1070
Medline Inc.
Loading chart...

Company Profile

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Latest News

Related stocks

RMD
RMD • United States
ResMed Inc.
230.05 USD
32.35B USD 1Y -19.7%
RMD.AX
RMD.AX • United States
RESMED CDI 10:1 [RMD]
32.58 AUD
32.02B USD 1Y -23.3%
BDX
BDX • United States
Becton, Dickinson and Company
183.75 USD
50.05B USD 1Y +19.9%
WST
WST • United States
West Pharmaceutical Services, I
366 USD
25.76B USD 1Y +35.6%
ISRG
ISRG • United States
Intuitive Surgical, Inc.
423.96 USD
149.78B USD 1Y -7.3%
SOLV
SOLV • United States
Solventum Corporation
87.29 USD
14.86B USD 1Y +19.3%
BAX
BAX • United States
Baxter International Inc.
24.35 USD
12.59B USD 1Y +5.1%
RGEN
RGEN • United States
Repligen Corporation
173.88 USD
11.04B USD 1Y +8.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 90.6 (Elevated multiple compression risk)
ende